Delivery Order SPE2DB20D3505-SPE2DB24FT5B9
- Not listed
- This federal contract award, valued at $18,466.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the pharmaceutical product EUCRISA 2% Ointment, 60 gm, and has a completion date of May 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $2,755.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% Ointment, a specialty pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,788.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUCRISA 2% ointment, a prescription medication, with a period of performance through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the procurement of a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,375.46 delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $2,062.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB24D1034|SPE2DB24FVYA7, is for the delivery of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2024 and is structured as a Firm Fixed Price Delivery Order. No set-aside designation was used for this...
- This federal contract award, with an ID of SPE2DX15D7056|SPE2DX24F1UDE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of EUCRISA 2% ointment in 60 gram tubes. The firm fixed price delivery order has a ceiling value of $1,341.26 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EUCRISA 2% Ointment 100GM. The contract has a ceiling value of $7,333.78 and is a firm fixed-price delivery order with a completion date of May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award, SPE2DX15D3402|SPE2DX25F1KDY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,487.36 firm fixed-price contract is for the delivery of EUCRISA 2% Ointment 60GM, a topical medication. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EUCRISA 2% ointment. The contract has a total ceiling value of $5,246.75 and a period of performance through July 16, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000 respectively, to provide a...
- The Defense Logistics Agency awarded a $3,664.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of EUCRISA 2% Ointment, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract was issued on January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT5B9Delivery Order
This federal contract award (SPE2DB20D3505|SPE2DB24FT5B9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,939.73 firm fixed-price delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/22/23 |